Immediate Impact

1 by Nobel laureates 60 standout
Sub-graph 1 of 23

Citing Papers

Accelerating antiviral drug discovery: lessons from COVID-19
2023 Standout
The evolution of SARS-CoV-2
2023 Standout
1 intermediate paper

Works of Tetsunari Maeda being referenced

Duration of fever and PA/I38X-substituted virus emergence in patients treated with baloxavir in the 2018–2019 influenza season
2019
Clinical Effectiveness of Oseltamivir and Zanamivir for Treatment of Influenza A Virus Subtype H1N1 with the H274Y Mutation: A Japanese, Multicenter Study of the 2007–2008 and 2008–2009 Influenza Seasons
2009

Author Peers

Author Last Decade Papers Cites
Tetsunari Maeda 274 69 10 35 12 283
Ken McPhie 175 94 5 34 11 269
Wenqing Zhang 209 78 9 35 14 275
L. B. Schonberger 127 64 3 85 13 270
T. L. Smith 172 43 11 40 17 304
R. J. R. Cureton 178 78 68 20 12 291
A. Ahmed 213 25 25 16 13 327
Jenna Elder 193 52 33 51 9 308
Marie-Jo Medina 223 58 112 22 7 312
C. Hallie Phillips 230 92 7 20 8 275
Andrew Catchpole 170 131 73 34 19 305

All Works

Loading papers...

Rankless by CCL
2026